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The monoclonal antibody 2D5 neutralized vaccinia virus by preventing penetration of the virus and reacting with VP23-
29K. The conformation of the VP23-29K was maintained by a disulfide bond(s), and the 2D5mAb reacted stronger with the
nonreduced 23-kDa form than with the reduced 29-kDa form. We selected several escape mutants. Sequences of the A17L
genes, which were thought to encode the VP23-29K, did not show cognate mutation. Genomic DNA of a 2D5mAb-resistant
mutant (M4) was cleaved with HindIII, and all the fragments were introduced into parental IHD-J strain vaccinia virus by
transfection. Only the L fragment produced a 2D5mAb-resistant virus. Dissection of the L fragment and subsequent transfec-
tion revealed that the L1R gene induced the 2D5mAb-resistant virus. The 2D5mAb-resistant mutants showed a consensus
G to A conversion at nucleotide 101 of their LIRs which would replace asparatic acid 35 with asparagine. Ishibashi-111
strain mousepox virus spontaneously resistant to 2D5mAb also had the same sequence at this region. Moreover, the VP23-
29K was myristoylated as predicted by the L1R gene. The coding gene of the VP23-29K was L1R. q 1996 Academic Press, Inc.
Vaccinia virus infects cells by means of membrane virus did not cause cell fusion, while the M4 mutant in-
duced cell fusion at the late stage of infection.fusion and induces syncytia at the late stage of infection.
The inhibition of the membrane fusion phenomena by a The 2D5mAb-resistant mutants were tested using
three anti-VP23-29K mAbs (Table 1). The M1, M2, andmonoclonal antibody (2D5mAb) suggests that its target
antigen has an important role in the processes. The M4 mutant viruses were resistant to the 2D5mAb and
G7H5mAb, whereas the 8C2mAb neutralized them with2D5mAb reacts with nonreduced 23-kDa protein and with
reduced 29-kDa protein of the virus, and we termed this the same efficiency as the parental IHD-J strain virus. All
three mAbs neutralized the CPR-C1 strain of cowpox andprotein VP23-29K (1, 2). N-terminal amino acid sequence
Copenhagen strain of monkeypox viruses, but the Ishi-analysis indicates its coding gene to be A17L. However,
bashi-111 strain of mousepox virus was resistant to theunlike the nonreduced 23-kDa form, the reduced 29-kDa
2D5/G7H5mAb and sensitive to the 8C2mAb. The VP23-protein reacted weakly with the 2D5mAb, and direct N-
29K had two distinct neutralizing epitopes. One was reac-terminal amino acid sequencing of the 29-kDa protein
tive to 2D5mAb/G7H5mAb, and the other was defineddid not produce signals. Recently the 2D5mAb was re-
by 8C2mAb. The 8C2-reactive epitope was conservedported to react with L1R encoded protein that behaved
among a wide range of orthopoxviruses, whereas thelike VP23-29K (3).
2D5/G7H5mAb-reactive epitope varied between the M1/To further characterize the VP23-29K, we selected mu-
M2/M4/mousepox and vaccinia/cowpox/monkeypox vi-tants that were resistant to neutralization by the 2D5mAb.
rus groups.Vero cells infected with the IHD-J strain of vaccinia virus
Structural proteins of the three 2D5mAb-resistant mu-were incubated in the presence of a mutagen (MNNG) to
tants were separated by SDS–PAGE and then immu-induce point mutations into the progeny virus (4). Mutant
noblotted against 2D5mAb and 8C2mAb (Fig. 1). Twoviruses were treated with trypsin to remove extracellular
vaccinia viruses (IHD-J and WR strains) and vaccinia mu-enveloped virus (EEV), because the EEV was resistant
tants (D1 and vRB10), the CPR-C1 strain of cowpox, theto neutralization (5). The activated viruses were selected
Ishibashi-111 strain of mousepox, and the Copenhagenby the 2D5mAb. After three repeated selective passages,
strain of monkeypox virus were examined in parallel. Allthe titer of the progeny virus was no longer reduced by
the virus samples were adjusted to 20 mg/lane. Profilesexposure to the 2D5mAb. Three clones (M1, M2, and M4)
of the viral proteins were revealed by silver staining thewere isolated and plaque purified. Cells infected with the
gel (Figs. 1A-1 and 1B-1) and by immunoblotting withM1 and M2 mutants as well as the parental IHD-J strain
polyclonal mouse anti-IHD-J strain vaccinia virus (Figs.
1A-2 and 1B-2). The profiles in the Fig. 1A (reduced pro-
teins) and Fig. 1B (nonreduced proteins) were different1 To whom reprint requests should be addressed.
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TABLE 1 the nonreduced 23-kDa protein was a highly antigenic
component common to all the tested viruses.Sensitivity of Viruses to Neutralizing Antibodies
When the samples were stained with the 2D5mAb
Neutralizing titer (50% plaque reduction) (Figs. 1A-3 and 1B-3), vaccinia viruses (IHD-J strain/WR
strain/D1 mutant/vRB10 mutant), the CPR-C1 strain of
Virus 2D5 8C2 G7H5 Anti-vaccinia cowpox virus, and the Copenhagen strain of monkeypox
virus showed VP23-29K profiles similar to those of theVaccinia IHD-J 105.8 103.8 103.2 103.5
reduced (29 kDa) and nonreduced forms (23, 21, andM1 mutant 102 103.1 102 103.3
M2 mutant 102 103.4 102 103.5 19 kDa). In contrast, M2 mutant/M4 mutant/mousepox
M4 mutant 102 103.2 102 103.0 viruses did not react with the 2D5mAb. The nonreduced
VP23-29K of the M1 mutant reacted with the 2D5mAbCowpox CPR-C1 106.2 102.9 102.2 103.2
Monkeypox 106.7 103.5 102.6 103.5 but the reduced form did not. All the virus reacted with
Copenhagen the 8C2mAb at the nonreduced 23 kDa (Fig. 1B-4), but
Mousepox Ishibashi-111 102 103.2 102 103.1
the 8C2mAb-reactive epitope disappeared after reduc-
tion. The 8C2mAb did not react with 21- and 19-kDaNote. Purified IMV samples were diluted with DMEM to give a titer
of 2000 PFU/ml. Monoclonal antibodies and anti-vaccinia serum (1, 5, proteins. The results indicated that the 2D5mAb-resistant
13) were first diluted to 1/100 and then serially diluted by 3.2-fold. Virus nature of the M2/M4/mousepox viruses coincided with
solution (0.5 ml) was mixed with an equal volume of antibody and the lack of reactivity against their VP23-29K. The VP23-
inoculated into Vero cell cultures (12-well plate, 50 ml/well) for plaque
29K of the M1 mutant had a variation different from thoseassay. Each value represents the mean of four assays.
of the M2/M4/mousepox viruses.
A DNA fragment containing the promoter and the en-
tire ORF sequence of A17L was cloned from genomicdue to a change of the protein configuration by reduction.
DNA of the IHD-J and the mutant viruses and then se-The relationships are shown in the two-dimensional elec-
quenced. The A17L genes of the M1 and M2 mutantstrophoresis profiles presented in the literature (1, 6, 7).
and parental IHD-J strain virus were identical to that ofOverall, the viruses presented similar profiles except for
the Copenhagen strain of vaccinia virus (8), except for Ga lack of VP32K in the D1 mutant virus (A-1) and slight
to A conversions at the nucleotides 120 and 360. Thedifferences in the cowpox and mousepox viruses. The
A17L of the M4 mutant contained a single point mutationsilver-stained profiles indicated that VP23-29K was a mi-
(C to T) at the nucleotide 226 which would substitutenor component of the viruses, but the profiles stained
with polyclonal anti-vaccinia mouse serum indicated that serine for proline 67. To examine whether the corre-
FIG. 1. VP23-29K of orthopox viruses and 2D5mAb-resistant mutants. IHD-J strain vaccinia virus (lane 1), WR strain vaccinia virus (lane 2), D1
mutant (14) (lane 3), vRB10 mutant (15) (lane 4), M1 mutant (lane 5), M2 mutant (lane 6), M4 mutant (lane 7), CPR.C1 strain cowpox virus (lane 8),
Ishibashi-111 strain mousepox virus (lane 9), and Copenhagen strain monkeypox virus (lane 10). The viruses were dissolved in reducing lysis buffer
(A) or in nonreducing lysis buffer (B) and immunoblotted. (A-1 and B-1) Silver-stained profiles of viral proteins. (A-2 and B-2) Immunoblotting profiles
with polyclonal anti-IHD-J strain vaccinia virus mouse serum. (A-3 and B-3) Immunoblotting profiles with 2D5mAb. (B-4) Immunoblotting profiles with
8C2mAb.
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FIG. 2. Nucleotide sequences of A17L and L1R. Genomic DNA of CPR.C1 strain cowpox, Ishibashi-111 strain mousepox virus, and recHH1 was
applied to PCR. Primers are indicated at both ends by boldface letters. The PCR products were cloned into pBluescriptII (KS/ and SK/) and then
sequenced. The sequences were lined up with those of the IHD-J strain vaccinia virus, as well as the M1, M2, and M4 mutants of which the entire
genes were sequenced.
sponding protein of mousepox virus varies from the with the other DNA fragments did not produce 2D5mAb-
resistant virus.VP23-29K at amino acid 67 or nearby, the genetic region
encoding amino acid residues 37–116 was amplified by The HindIII L fragment of the M4 mutant DNA was
cloned into a plasmid and cleaved with XbaI. The leftPCR and sequenced (Fig. 2). The A17L equivalents of
mousepox and cowpox viruses showed several different half contained part of G9R, L1R, and a portion of L2R
(nucleotide sequence of 79244–80965). The fragmentnucleotides, but the amino acid residues were not af-
fected. Mousepox and cowpox viruses had amino acid was further cleaved with BamHI and the left end of Hin-
dIII/BamHI was digested for about 150 nucleotides.sequences identical to that of the IHD-J strain virus con-
cerning this region. The A17L genes of M1/M2/ Transfection with this fragment (L1R of the M4 mutant)
produced 2D5mAb-resistant virus.mousepox viruses were not involved in the antigenic vari-
ation found in their VP23-29K. The L1Rs of IHD-J, M1, and M4 viruses were se-
quenced. The M1 and M4 viruses contained the identicalThe resistance to 2D5mAb was considered to be en-
coded by a gene other than A17L. Genomic DNA of the mutation of G to A at nucleotide 101 of the L1R ORF
(80256). There was no other difference in the L1Rs. TheM4 mutant virus was digested with HindIII, and the gen-
erated A to P fragments were isolated by agarose gel mutation would substitute asparagine for aspartic acid
35. Part of the L1R ORF (80150–80378), correspondingelectrophoresis. Each of the DNA fragments was
transfected into CV-1 cells infected with IHD-J strain virus to the coding region of the amino-terminal 74 amino acid
residues, was amplified from genomic DNAs of the M2(9), and the progeny was screened with the 2D5mAb.
Resistance to the 2D5mAb was found in the progeny mutant, mousepox, and cowpox viruses (Fig. 2). The M2
mutant and mousepox virus contained the same variationvirus grown in cells transfected with the L fragment. The
virus (recHH1) was plaque purified. Cultures transfected as that of M1/M4 mutants, whereas the amino acid se-
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was purified. The IMV was dissociated in nonreducing
lysis buffer and then precipitated with the 8C2mAb or
2D5mAb. The immune complex was collected on protein
A–agarose beads and dissolved for electrophoresis (Fig.
3). When the immunoprecipitate by the 2D5mAb was dis-
sociated with nonreducing buffer, the 2D5mAb reacted
with the 23- and 21-kDa proteins (Fig. 3B). The 8C2mAb
reacted with its 23-kDa band, and distribution of tritium-
labeled myristoylated protein coincided with the 23-kDa
band. On the other hand, the 8C2mAb precipitated only
the 23-kDa myristoylated protein, and it reacted with the
2D5mAb. Neither the 21- nor the 19-kDa protein was
detectable in the 8C2mAb precipitate. The myristoylated
protein in the precipitates migrated as a 29-kDa protein
after reduction (Fig. 3A), and the reduction diminished
FIG. 3. Immunoprecipitation of VP23-29K. Purified intracellular ma-
antigenicity of the 21- and 19-kDa proteins. These resultsture virus (IMV, 200 mg), labeled with [3H]myristic acid, was dissoci-
indicated that the gene encoding the VP23-29K was L1R,ated with 1% SDS (1 ml) and passed through a column to remove
the SDS. The 2D5mAb or 8C2mAb (1/500 diluted, 500 ml) was mixed as reported by Wolffe et al. (3), and that the VP23-29K
with an equal volume of the lysed sample. As the 8C2mAb did not corresponded to the myristoylated protein M25 reported
adsorb to protein A, anti-mouse IgG (1/500 diluted, 30 ml, Bio-Rad) by Franke et al. (10). The 2D5mAb recognized epitopes
was added to the mixture. Immune complexes were collected using
on the nonreduced 21- and 19-kDa proteins and VP23-protein A – agarose beads (Oncogene, 30 ml). After several washes,
29K of IMV. The natures of the 21- and 19-kDa proteinsthe adsorbed complex was released by reducing lysis buffer for
electrophoresis (A) or by nonreducing lysis buffer (B). Nonreducing were not clear.
lysis conditions disassembled the immune complex, but immuno- The A17L product (VP21K) is assembled to the spheri-
globulin was not dissociated into L and H chains. (A) Lane 1: Purified cal membrane of the immature virus (11), and then the
virus processed in parallel. Viral proteins were stained with poly-
VP23-29K is targeted for the membrane (12). Study of theclonal anti-vaccinia mouse serum. Lane 2: Precipitate with 2D5mAb
assembly/disassembly mechanism of functional fusionwas immunostained with the 2D5mAb. Lane 3: Autoradiograph of
the lane 2 filter strip. Lane 4: Precipitate with 8C2mAb was immuno- apparatus will give further insight into the membrane
stained with the 2D5mAb. (B) Lane 1: Purified virus processed in fusion process.
parallel. Viral proteins were stained with polyclonal anti-vaccinia
mouse serum. Lane 2: Precipitate with 2D5mAb was immunostained ACKNOWLEDGMENTS
with the 2D5mAb. Lane 3: Precipitate with 2D5mAb was immuno-
stained with the 8C2mAb. Lane 4: Autoradiograph of lane 2 filter We thank Dr. B. Moss for informing us about reactivity of the 2D5mAb.
strip. Lane 5: Precipitate with 8C2mAb was immunostained with the This work was supported by a grant-in-aid for scientific research from
2D5mAb. Lane 6: Autoradiograph of lane 5 filter strip. The Ministry of Education, Science and Culture, Japan.
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